Abstract
This article reviews epidemiological evidence of heritability and putative mechanisms in diverticular disease, with greatest attention to 3 recent studies of genetic associations with diverticular disease based on genome-wide or whole-genome sequencing studies in large patient cohorts. We provide an analysis of the biological plausibility of the significant associations with gene variants reported and highlight the relevance of ANO1, CPI-17 (aka PPP1R14A), COLQ6, COL6A1, CALCB or CALCA, COL6A1, ARHGAP15, and S100A10 to colonic neuromuscular function and tissue properties that may result in altered compliance and predispose to the development of diverticular disease. Such studies also identify candidate genes for future studies.
Keywords: Diverticulum, Diverticulitis, Diverticular Hemorrhage
Summary.
This article reviews epidemiological evidence of heritability and putative mechanisms in diverticular disease, with greatest attention to 3 recent studies of genetic associations with diverticular disease based on genome-wide or whole-genome sequencing studies in large patient cohorts.
Colonic diverticulosis is the most common finding on screening colonoscopy in the United States,1 and the prevalence of diverticulosis increases with age. Using national data from routine clinical colonoscopies, the prevalence of diverticulosis was 20% in individuals 40–49 years of age. The prevalence increased with every age group, reaching 75% in those 80 years of age and older.1 In a U.S. colonoscopy-based study aimed at detecting diverticulosis,2 the density, size, depth and distribution of diverticula also increased with age.
These false or pseudodiverticula are acquired with age and form when the colonic mucosa and submucosa herniate through vascular portals in the muscularis propria into the subserosa.3 In contrast with the United States, colonic diverticulosis is less prevalent in African and Asian countries and, when present, is usually right-sided,4, 5 although left-sided diverticula are becoming more frequent as shown in a recent report from Yokohama, Japan.6 African Americans in the United States are more likely to have right-sided diverticulosis.2
While diverticulosis is usually an incidental finding, some individuals with diverticulosis will go on to develop clinically significant complications.7 The complications are morbid, sometimes fatal, and responsible for $5.5 billion dollars in U.S. health care expenditures annually.8 The 2 most common complications of colonic diverticulosis are acute diverticulitis and diverticular hemorrhage. Acute diverticulitis is characterized by inflammation localized to a diverticulum and the surrounding mucosa. Acute diverticulitis is usually a self-limited event but relapses unpredictably in more than 20% of cases.9 In some cases of acute diverticulitis, the inflammation will lead to a phlegmon, abscess, bowel perforation, or peritonitis. Rarely, acute diverticulitis will become chronic or progress to a fistulizing or structuring disease. Chronic gastrointestinal symptoms are common after an episode of diverticulitis and attributed to postinflammatory visceral hypersensitivity.10, 11, 12 In contrast, diverticular hemorrhage is the result of rupture of an artery in the base or neck of a diverticulum without associated inflammation. Diverticular disease is a nonspecific term often used to describe diverticulosis and all potential complications, but is sometimes used to only describe the complications of diverticulosis.13 Most of the research to date has used the former. We used the term similarly in this review. When possible, we use more specific nomenclature (ie, diverticulosis and diverticulitis) because the mechanism by which colonic diverticula form may be entirely different from the mechanism by which diverticulitis or diverticular hemorrhage develops.14 This review does not include discussion of symptomatic uncomplicated disease, a debated condition used to describe patients with diverticulosis without diverticulitis and chronic gastrointestinal symptoms.11, 15, 16, 17
Epidemiological and Twin Studies Support Genetic Contribution to Diverticular Disease
Emerging evidence suggests that genes contribute to the risk of developing colonic diverticular disease. Using data from the Swedish Twin Registry, the odds of developing diverticular disease in siblings of index cases was 7-fold for monozygotic twins and 3-fold for dizygotic twins.18 A population-based study in Denmark found that the risk of developing diverticular disease in siblings of index cases was 14.5-fold for monozygotic twins, 5.5-fold for dizygotic twins, and 3-fold for siblings.19 The risk was significantly higher for siblings of cases with young-onset disease. Among twins, but not siblings, there was a marked difference in risk by sex, with strong evidence for a genetic effect in female twins, but not among male twins. Based on these 2 studies, the genetic contribution to diverticular disease is estimated at 40%–53%.
Diverticulosis: Prevailing Hypothesis of Fiber Deficiency Questioned
Historically, colonic diverticulosis was attributed to a low fiber diet. In 1971, Painter and Burkitt20 proposed that a low fiber diet resulted in smaller volume stool while the sigmoid colon would segment or functionally obstruct when the diet was deficient in bulk forming fiber.21 Over time, the colon wall was thought to “rupture” from excessive pulsion forces with formation of diverticula.21 The fiber hypothesis was based on ecologic observations—diverticulosis was rare in countries with high-fiber diets—and until recently, had never been formally studied. The fiber hypothesis was tested in 2 cross-sectional colonoscopy-based studies of well-characterized individuals (demographics, diet, and physical activity) presenting for a screening colonoscopy, thereby avoiding selection bias. In both studies, neither dietary fiber intake nor constipation was associated with an increased risk of colonic diverticulosis.22, 23 Measures of association were calculated with appropriate control for confounding variables. This work strongly challenged the hypothesis that diverticulosis is the result of a low fiber diet and created the space for alternative hypotheses.
Alternative Hypotheses for Diverticulosis: Altered Tissue Integrity, Sex Hormones, the Microbiome, and Inflammation
Diverticula form when colonic mucosa and submucosa herniate through the perivascular connective tissue envelope that surrounds the intramural vasa recta (Figure 1).14 As such, there is potentially a role for dysfunctional connective tissues, best illustrated by association of diverticulosis with both acquired24 and inherited connective tissue disorders including Marfan, Ehlers-Danlos, Coffin-Lowry, and Williams syndromes, reviewed by Reichert and Lammert,25 and aging (Figure 1). Dysfunctional connective tissues may predispose colonic mucosa and submucosa to herniate into the subserosa, and alter colonic compliance. There is lower compliance of the sigmoid compared with the transverse colon,26 which has similar compliance to the ascending colon.27 These observations might explain the higher prevalence of distal diverticulosis in Western populations. Collagen accounts for mechanical stability of connective tissues, and is altered in patients with a history of recurrent diverticulitis, as a reaction to chronic inflammation.28, 29, 30 In diverticulosis without diverticulitis, there is evidence for higher expression of matrix metalloproteinase-1 (ubiquitously expressed interstitial collagenase) and altered connectives tissues.31, 32, 33, 34, 35 While dysfunctional connective tissues or compliance contribute to the risk of distal diverticulosis, right-sided diverticulosis in Asian individuals4, 5 may suggest a genetic contribution.
Figure 1.
Colonic diverticula form when mucosa and submucosa herniate through the envelope that surrounds the intramural vasa recta; colonic dysmotility or structural weaknesses likely contribute to this pathology. Diverticular hemorrhage is an arterial bleed in an uninflamed diverticulum, with vascular disease or structural weakness likely playing a role. Acute diverticulitis is inflammation localized to a diverticulum and the surrounding mucosa triggered by microperforation or bacterial translocation, or focal ischemia.
Endogenous sex hormones may be associated with diverticulosis risk. In a prospective study of patients undergoing screening colonoscopy, diverticulosis was less prevalent in premenopausal age women compared with similar aged men.36 The prevalence of diverticulosis in men and women was the same after 50 years of age. This finding suggests that ovarian steroid hormones in premenopausal women may reduce the risk of diverticulosis, potentially via favorable effects of steroid hormones on collagen or elastin.37, 38 In the same study, general obesity increased the risk of diverticulosis in women, but not men.36 The increased risk was limited to women before the age of 60. Premenopauseal obesity may increase the risk of diverticulosis in women by decreasing circulating estrogen and increasing free testosterone.39
The development of colonic diverticulosis is unlikely to be related to an aberrant microbiota, based on absence of significant alterations in a careful study.40 Mucosal inflammation is also unlikely to play a role; in a colonoscopy-based study, there was no association between markers of chronic mucosal inflammation and diverticulosis.16
Diverticulosis and Motility: Neuromuscular Mechanisms and Receptors
Studies utilizing full-thickness human sigmoid colons with diverticulosis have found significant alterations in enteric smooth muscle in noninflamed regions. Such studies documented severely reduced spontaneous motility and enhanced neutrally mediated sigmoid colon tissue responses,41 multiple molecular alterations involved in smooth muscle contractile functions,42 increased ratio of connective tissue within the longitudinal muscle layer, or increased thickness of the circular and longitudinal muscle layer, structural alterations of smooth muscle cells, and decreased expression of functionally relevant myofilament types.33 One study reported downregulation of 5-hydroxytryptamine receptor 4 receptors (which are involved in stimulation of peristalsis) in colons with diverticulosis.43
Descriptive motility studies suggested compartment formation in sigmoid colons with diverticulosis,21, 23 leading to elevated segmental pressures. These provocative studies did not formally compare motility measurements in healthy subjects, and may have involved selection, age or sex bias. There are no contemporary studies of colonic motility in patients with diverticulosis without such biases.44
Diverticulitis: Compelling Evidence that Diet and Lifestyle Contribute to Risk
In addition to the genetic contribution described previously, there is strong evidence that age, female sex, diet, and lifestyle contribute to the risk of diverticulitis.45 Similar to diverticulosis, diverticulitis risk increases with age.46 Likewise, premenopausal age women are protected from diverticulitis compared with similar-aged men.46 Unlike diverticulosis risk, the risk of diverticulitis increases significantly in women after the age of menopause and is greater in women over 60 years of age compared with similar-aged men.46 Menopausal hormone therapy increases the risk.47 In well-characterized prospective cohort studies, obesity, a Western diet (including low dietary fiber and high red meat intake), physical inactivity, and smoking increase the risk of diverticulitis.45, 46, 48, 49, 50, 51, 52 Regular use of nonsteroidal anti-inflammatory drugs doubles the risk,53 and chronic immunosuppression54 is also a risk factor for diverticulitis and the more serious complications, such as abscess and perforation.
Diverticulitis Pathophysiology: Dysmotility, the Microbiome, and Inflammation
Similar to diverticulosis, the etiopathogenesis of diverticulitis is poorly understood. Some authors have hypothesized that diverticulitis is the result of inspissated stool eroding through the diverticular wall (Figure 1).55 It has also been suggested that peridiverticular submucosal blood vessels can become compromised causing local ischemia and inflammation.14 There is a theory that a narrow necked diverticulum does not empty well and that increased exposure time to stool facilitates translocation.14 Finally, the fundus of the diverticulum (with only a serosal covering) may become distended to the point of microperforation.14
There are a number of factors that may contribute to diverticulitis pathogenesis. Dysmotility may play a role in the pathogenesis of diverticulitis. In preliminary work, more frequent bowel movements at baseline were associated with diverticulitis risk.56 Studies utilizing full-thickness human sigmoid colons electively resected for diverticular disease (usually diverticulitis) found hypoganglionosis of the enteric nervous system,57 altered GDNF/Ret signaling in the myenteric plexus,58 altered expression of the homeobox transcription factor Phox2b57 and abnormalities in longitudinal muscle relaxation.59 Recurrent diverticulitis may induce changes in the enteric nervous system or these factors may be associated with diverticulosis pathogenesis but not progression to diverticulitis. In a single multigenerational family with early onset diverticulitis, whole exome sequencing was performed and identified a variant in the LAMB4 gene. This protein plays a role in the function of the enteric nervous system.60
If the fecalith or distended diverticulum hypotheses are true, dysfunctional connective tissues may not only predispose to diverticulosis pathogenesis, but may also contribute to diverticulitis. In diverticulitis, there is evidence for diffuse alterations in concentrations of matrix metalloproteinases and tissue inhibitors of metalloproteinases61 and elastosis.62 Because connective tissue is changed by chronic inflammation, it is difficult to determine whether these changes occurred before the development of diverticulitis.
The gut microbiome may play a role in the pathogenesis of diverticulitis.13, 63 Gut dysbiosis is associated with mucosal barrier defects and local immune dysfunction and these derangements may contribute to the mucosal inflammation of diverticulitis. This hypothesis is based on evidence that aging, smoking, obesity, a Western diet, and physical inactivity are associated with dysbiosis and diverticulitis risk. Antibiotics use also leads to an unbalanced microbial community, and there are preliminary data that chronic antibiotic use is associated with developing diverticulitis.64 Previous studies of the microbiome in patients with diverticulitis are based on small cohorts that assessed the microbiome after diagnosis and antibiotic exposure, which may cause dysbiosis.65, 66, 67, 68 Because the majority of individuals with diverticulosis have multiple colonic diverticula and diverticulitis is a focal disease, the contribution of dysbiosis is likely in addition to other factors. The gut microbiome is modifiable, which makes understanding how the microbiota contributes to the inflammatory cascade of diverticulitis an important next step in understanding diverticulitis pathogenesis.
Chronic inflammation is suspected to contribute to diverticulitis risk based on the evidence that obesity, a Western diet, and physical inactivity are risk factors.13 Likewise, statins reduce the risk, albeit this evidence is limited.69 There is preliminary evidence that plasma levels of inflammatory (C-reactive protein and interleukin-6) biomarkers are elevated before a diagnosis of diverticulitis, which more directly supports a role for chronic, systemic inflammation.70 There are multiple inflammatory pathways that could plausibly increase the risk of diverticulitis. Several trials of anti-inflammatory and immunosuppressive drugs for inflammatory bowel disease did not reduce the risk of recurrent disease, which suggests that these diseases do not share a common inflammatory pathway.9 Additionally, corticosteroids and nonsteroidal anti-inflammatory drugs increase, not decrease, diverticulitis risk.
Chronic inflammation plays a role in cardiovascular disease. Diverticulitis and cardiovascular disease share several risk factors including obesity, physical inactivity, a Western diet, smoking, and chronic corticosteroid use, and among women, being postmenopausal. In a large population-based study, incident diverticular disease was associated with development of acute myocardial infarction, stroke, venous thromboembolism, and subarachnoid hemorrhage. This risk remained even after excluding the first year of follow-up.71 This study raises the question of whether vascular disease contributes to diverticulitis risk similar to heart disease. Given the shared risk, factors this is a feasible hypothesis.
Diverticular Hemorrhage: Pathophysiology and Epidemiology
The second-most-common complication of colonic diverticulosis is diverticular hemorrhage, an arterial bleed from the base or neck of an uninflamed diverticulum. Diverticular hemorrhage is the most common cause of lower gastrointestinal bleeding, but is difficult to diagnosis and is most commonly a presumed diagnosis, making research difficult.72 Diverticula proximal to the splenic flexure are more likely to bleed compared with diverticula in the descending and sigmoid colon.14 Some authors have hypothesized that diverticular hemorrhage is the result of inspissated stool causing trauma (Figure 1).14 Mechanical vulnerability has also been proposed.14 Diverticular hemorrhage is most common in U.S. adults over 60 years of age and African Americans.73 Obesity, physical inactivity, hypertension, diabetes, and vascular disease increase the risk.51, 52, 74 Regular use of nonsteroidal anti-inflammatory drugs is also a risk factor.75 Recurrent hemorrhage is common with 15% risk recurrence in 5-year follow-up.76
Multiple Genetic Association Studies Identify Possible Loci
Genome-wide association studies (GWASs) aimed at discovery of variants associated with diverticular disease have implicated several novel genes. These studies are summarized in Table 1, which provides information at the discovery and replication stages. To date, at least 35 loci are associated with diverticular disease. In contrast with other works,77, 78 the tumor necrosis superfamily 15 gene was not identified in GWASs.
Table 1.
Extensive Genome Studies of Association Diverticular Diseases
| Discovery Stage |
Replication Stage |
Combined Analysis |
|||||
|---|---|---|---|---|---|---|---|
| Population | Sample Size | Genome-Wide Significant Loci | Population | Sample Size | Genome-Wide Significant Loci | Genome-Wide Significant Loci | Reference |
| Icelandic population | 5426 cases diverticular disease1 2764 cases diverticulitisa 245,951 controls |
3 | Danish National Biobank | 5970 cases diverticular diseaseb 3020 controls |
3 | 3 | 88 |
| UK Biobank | 27,444 cases diverticular diseasec 382,284 controls |
40 | Michigan Genomics Initiative | 1854 cases diverticulosisd 718 cases diverticulitis 28,649 controls |
8 | NA | 89 |
| UK Biobank | 31,964 cases diverticular diseasee 419,135 controls |
48 | Germany, Austria, Lithuania, and Sweden | 3893 cases diverticular diseasef 2829 diverticula-free controls |
27 | 35 (meta-analysis using Michigan data from ref. 89) | 85 |
Diverticular disease included individuals with diverticulosis and any potential complication. Cases of diverticular disease were defined as an individual with an International Classification of Diseases-Ninth Revision (ICD-9) code 562.1-2 or International Classification of Diseases-Tenth Revision (ICD-10) code K57.2-9. Patients who came to the hospital for diverticulitis complications or if the diagnosis was coupled to a resection of the left colon or sigmoid colon were classified as diverticulitis.
Diverticular disease included individuals with diverticulosis and any potential complication. Cases were defined as an ICD-9 code 562.1-2 or ICD-10 code K57.2-9.
Diverticular disease included individuals with diverticulosis and any potential complication. Cases were defined as an individual with any ICD-10 K57 code.
Diverticulosis cases were defined by individuals with ICD-9 562.10 or 562.12 code. Diverticulitis cases were defined by individuals with an ICD-9 562.11 or 562.13 code.
Diverticular disease included individuals with diverticulosis and any potential complication. Defined as an individual with an ICD-9 code 562 or ICD-10 K57 in the UK Biobank dataset for primary, secondary, and self-reported diverticular disease diagnosis.
Diverticular disease included individuals with diverticulosis and any potential complication. The German and Lithuanian samples were phenotyped by review of colonoscopy reports, hospital admissions, and ambulatory clinic records to identify cases with diverticulosis and diverticulitis, and diverticula-free controls. The Austrian samples were phenotyped by review of colonoscopy and clinical data. The Swedish samples were phenotyped based on colonoscopy reports to identify cases with or without diverticulosis.
Biological Plausibility of Suggested Gene Variants in Diverticular Disease
Given the identification of these genetic loci (Table 2), we have evaluated the biological plausibility of a role in development of diverticular disease, based on the actions of the genes themselves and the impact of the gene variants. The reported variants can be classified into 5 groups (Table 2) based on association with altered smooth muscle or nerve functions, connective tissue function, possible association with other bowel functions (eg, epithelial or immune), biological or clinical relevance unrelated to bowel function, and uncharacterized single nucleotide polymorphisms (SNPs) or unnamed single nucleotide variants (SNVs) of unclear biological or clinical significance.
Table 2.
Functions of Gene Variants Associated with Diverticulosis, Diverticular Disease, or Diverticulitis
| Nearest Gene | Full Name | Functions of Genes | SNP/SNV | Associations With Colon Functions | Mechanistic Effects of Variants | Discovery Reference(s) | Mechanism Reference(s) |
|---|---|---|---|---|---|---|---|
| Gene variants associated with altered smooth muscle or nerve function | |||||||
| FADD or ANO1 |
FADD = Fas associated via death domain; ANO1 = Anoctamin 1, aka trans-membrane protein 16A (TMEM16A) |
FADD associated with colon cancer and Crohn’s disease; ANO1 related to gastrointestinal pacemaker activity | rs875107 rs72945112 |
DD and D-osis (89); DD (85) Hirschsprung disease and functional constipation |
Intronic SNP of UNCS; ANO1 Influences Ca2+-activated Cl– channel in epithelia and ICCs |
85, 89 | 90, 91, 92 |
| ARHGAP15 | Rho GTPase activating protein 15 | Negative regulator of neutrophil functions; affects the architecture and function of hippocampal inhibitory neurons and causes cognitive deficits | rs4662344 | DD (85,88) Hirschsprung in Mowat-Wilson syndrome |
Intronic SNP of UNCS; Overexpression results in an increase in actin stress fibers and cell contraction | 85, 88 |
93, 94, 95 96 97 |
| rs6734367 | DD and D-osis (89) | Intronic SNP of UNCS | 89 | ||||
| COLQ or METTL6 | COOH-terminal collagen Q; Methyltransferase like 6 | Collagen-like tail subunit of asymmetric acetyl-cholinesterase; controls postsynaptic differentiation at neuromuscular junction | rs7609897 | DD (88) DD and D-itis both borderline significant (89) DD (85) |
COLQ affects acetylcholinesterase; Congenital myasthenic syndrome | 85, 88, 89 |
98 99 100 101 |
| PPP1R14A (aka CPI-17) or SPINT2 | protein phosphatase 1 regulatory inhibitor subunit 14A or serine peptidase inhibitor, Kunitz type 2 | CPI-17 is a phosphorylation-dependent inhibitory protein for smooth muscle myosin phosphate (including colon); Downregulation of CPI-17 expression causes sustained contraction in colonic muscle; CPI-17 may cause reduced contraction in aging rat colon | rs11667256 | DD and D-osis borderline significant (89) DD (85) |
SNP of UNCS; however, mutations in SPINT2 result in congenital sodium diarrhea | 85, 89 | 102, 103, 104 |
| P2RY12 | purinergic receptor P2Y12 | Critical role in platelet function and microglia neuronal function | rs3732760 | DD (85) | Intronic SNP of UNCS; | 85 |
105 or 106 |
| CALCB, or CALCA | calcitonin related polypeptide beta | Afferent nerve function and calcium balance, vasodilators with signaling mechanisms in vascular endothelium and smooth muscle | rs575909118 or 12293535 or 12293178 |
D-itis > D-osis (85) | SNVs of UNCS | 85 | 107 |
| COL6A1 | collagen type VI alpha 1 chain | Association with muscular dystrophies/myopathies and ossification of ligaments; Collagen VI regulates peripheral nerve myelination and function; Lack of collagen VI promotes neurodegeneration |
rs7281388 | DD (85) | Intronic SNP of UNCS; a COL6A1 mechanism associated with Hirschsprung disease by interfering with colonization of the bowel by enteric neural crest cells | 85 |
108, 109, 110, 111, 112 113 114 |
| Gene variants with conceivable associations with other bowel functions (eg, epithelial or immune) | |||||||
| PHGR1 or DISP2 | PHGR1 proline, histidine and glycine rich 1 or DISP2 dispatched RND transporter family member 2 | Epithelial dysfunction, high expression in colon and small intestine | rs71472433 | D-itis > D-osis (85) | Intronic SNP of UNCS; | 85 | 115 |
| ABO | ABO, α 1-3-N-acetylgalactosaminyl-transferase and α 1-3 galactosyl-transferase | Gene encodes proteins related to blood group system, ABO; Expression in colon, small bowel |
rs582094 | DD and D-itis (89) DD (85) |
Intronic SNP of UNCS | 85, 89 | 116 |
| Gene variants associated with altered connective tissue | |||||||
| S100A10 | S100 calcium binding protein A10 | Regulates the remodeling of the extracellular matrix | rs61814883 | D-itis > D-osis (85) | Intronic SNP of UNCS; | 85 | 117 |
| BMPR1B | bone morphogenetic protein receptor type1B | Protects neurons against kainic acid-induced neurodegeneration | rs1544387 | DD and D-itis (89); DD (85) |
Intronic SNP of UNCS; | 85, 89 |
118 119 |
| ELN or L1MK1 | Elastin gene and LIMK1 (ELASTIN) LIM domain kinase 1 | Extracellular matrix protein responsible for arterial resilience and skin integrity; Associated with aneurysms (eg, Marfan) and cutis laxa | rs3823878 | DD and D-osis (89) DD (85); abnormalities in longitudinal muscle relaxation and content of elastin in uncomplicated DD |
Intronic SNP of UNCS; | 85, 89 | 59 |
| EFEMP1 | Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 | extracellular matrix protein associated inguinal hernias and varicose veins, carpal tunnel syndrome, and biliary atresia; association with risk of glioma in Chinese | rs1802575 | DD (89) | Not found in gene, genome, OMIM, or PubMed databases | 85 | 120 |
| Gene variants with biological or clinical relevance, but unrelated to bowel functions | |||||||
| SLC35F3 | solute carrier family 35 member F3 | Gene involved in hypertension and thiamine transport | rs43333882 | DD and D-osis (89) DD (85) |
Intronic SNV of UNCS | 85, 89 | 121 |
| GPR158 | G protein–coupled receptor 158 | Gene involved in cognition | rs7086249 | DD and D-itis (89) DD (85) |
Intronic SNV of UNCS | 85, 89 |
122 123 associated with obesity in Pima Indians |
| FAM155A | family with sequence similarity 155 member A | Mainly expressed in hypothalamus and pituitary gland with low expression in colon | rs67153654 rs9555371 rs9520344 |
DD (88) D-itis > D-osis (85) |
Intronic SNP of UNCS | 85, 88 | 124, 125 |
| rs11619840 | DD and D-osis (89) | Intronic SNP of UNCS | 89 | ||||
| rs9520339 | DD (85) | Intronic SNP of UNCS | 85 | ||||
| SHFM1 or CLSTN2 | SHFM1 split hand/foot malformation (ectrodactyly) type 1; CLSTN2 calsyntenin 2 | CLSTN2 with human memory, Alzheimer’s disease, neural development | rs3113037 | DD and D-osis (89) | Upstream variant | 85, 89 |
126, 127 128 |
| CTAGE1 | cutaneous T-cell lymphoma-associated antigen 1 | Expression of CTAGE-1 restricted to normal testis or most tumors | rs9960286 | DD (85) | Intergenic; SNP of UNCS | 85 | 129 |
| GTPBP1 | GTP binding protein 1 | Upregulated by interferon gamma and encodes a protein that is a member of the AGP11/GTPBP1 family of GTP-binding proteins | rs138699 | DD and D-osis (89) | Intronic SNP of UNCS | 89 | 130 |
| ISL2 or ETFA or SCAPER |
ISL2 ISL LIM homeobox2; ETFA electron transfer flavoprotein subunit α; SCAPER S-phase cyclin A associated protein in the Endoplasmic Reticulum |
ISL2 transcription factor essential for motor neuron development; SCAPER involved in cell cycle progression |
rs2056544 rs10519134 |
DD borderline significant (85); DD and D-osis (89) ETFA variant: susceptibility to glioma; SCAPER variant: Bardet-Biedl syndrome, retinitis pigmentosa, Parkinson’s |
Intronic SNP of UNCS; | 85, 89 | 131, 132 |
| TNRC6B | trinucleotide repeat containing adaptor 6B | Involved in RNA interference machinery; Associated with prostate cancer, leiomyoma |
rs5995842 | DD (85) | Intronic SNP of UNCS; | 85 | 133 |
| SNX24 | sorting nexin 24 | Involved in endocytosis and protein trafficking; Gene variant associated with coronary aneurysm in Kawasaki disease |
rs34126945 | DD (85) | Intronic SNP of UNCS; | 85 | 134 |
| C1QTNF7 (aka CTRP7) | C1q and tumor necrosis factor-α-related protein 7 | Gene related to adiponectin gene and induces AMP-activated protein kinase phosphorylation, increased glycogen accumulation, and fatty acid oxidation | rs4515160 | DD (85) | Intronic SNP of UNCS; variants in C1QTNF7 gene associated with conduct disorder in childhood | 85 | 135, 136 |
| PIAS1 | protein inhibitor of activated STAT 1 | Protein inhibitor of activated STAT proteins are multifunctional nuclear proteins operating in immune system; Associated with Huntington's and other neurodegenerative disorders | rs387505 | DD (85) | Intergenic; SNP of UNCS | 85 | 137 |
| HLX | H2.0 like homeobox | Involved in hematopoiesis and fetal growth; Candidate gene for anomalies associated with congenital diaphragmatic hernia, short bowel, and asplenia or childhood asthma |
rs2784255 | DD (85) | Intergenic; SNP of UNCS | 85 | 138, 139, 140 |
| FBXL13 or FAM 185A | FBXL13 F-box and leucine rich repeat protein 13; FAM 185A family with sequence similarity 185 member A | Possible association with success at smoking cessation | rs10257317 | DD (85) | Intronic SNP of UNCS; | 85 | 141 |
| LINC01082 | long intergenic non–protein coding RNA 1082 | Associated with alveolar capillary dysplasia | rs2280028 | DD (85) (borderline) | Intergenic (downstream); SNP of UNCS | 85 | 142 |
| DISP2 | dispatched RND transporter family member 2 | Described in drosophila, zebrafish and gastric cancer | rs71472433 | DD (85) (borderline) | Intronic SNP of UNCS | 85 | 143 |
| CACNB2 | calcium voltage-gated channel auxiliary subunit beta 2 |
CACNB2 is 1 of 4 homologous genes coding for the auxiliary Cavβ subunits, which are important modulators of the Ca2+ channel activity; CACNB2 gene linked to 5 mental, 3 cardiovascular diseases |
rs1888693 | DD (85) (borderline) | Intronic SNP of UNCS | 85 | 144 |
| NOV | Nephroblastoma overexpressed gene | NOV encodes a secreted cysteine-enriched multimodular protein that acts as a localized multivalent signal integrator; highly expressed in the nervous system, especially in the spinal cord and in the dorsal root ganglion during development | rs60869342 rs1381335 | DD (89) | rs60869342:SNV of UNCS rs1381335 Not found in gene, genome, OMIM, or PubMed databases |
85, 89 | |
| EDEM 1 | ER-degradation-enhancing alpha-mannosidase-like protein-1 | EDEM 1 associated with the development of hepatocellular carcinoma | rs7624168 | DD (85) | Intergenic SNV of UNCS | 85, 89 | 145 |
| LYPLAL1-AS1 | lysophospholipase like 1 antisense RNA 1 | Association with hypertension, obesity and nonalcoholic fatty liver disease | rs61823192 | DD (89) | Not found in gene, genome, OMIM, or PubMed databases | 85 | |
| SLC25A28 | solute carrier family 25 member 28 | nuclear-encoded transporters embedded in the inner mitochondrial membrane (specifically mitoferrin 2 which is ubiquitous (heart, liver, kidney | rs7098322 | DD (89) | Not found in gene, genome, OMIM, or PubMed databases | 85 | 146 |
| SLC4A1 | solute carrier family 4 member 1 | Associated with renal tubular acidosis and RBC senescence | rs8074740 | DD (85) | Intergenic SNV of UNCS | 85 | 147 |
| CWC27 | spliceosome associated cyclophilin | Associated with retinal degeneration, brachydactyly, craniofacial abnormalities, short stature, and neurological defects | rs10471645 | DD (85,89) | Intronic SNV of UNCS | 85 | 148 |
| Uncharacterized SNPs or unnamed SNVs of unclear biological or clinical significance | |||||||
| LOC101927314 | Uncharacterized | rs4839715 | DD (Euro) (borderline) | Intronic SNP of UNCS; | 85 | ||
| unnamed | rs11619840 | DD and D-osis | Intronic SNV of UNCS | 89 | |||
| unnamed | rs72945112 | DD and D-osis | SNV of UNCS | 89 | |||
| unnamed | rs10519134 | DD and D-osis | Intronic SNV of UNCS | 89 | |||
D-itis, diverticulitis; D-osis, diverticulosis; DD, diverticular disease; ICC, interstitial cells of Cajal; OMIM, Online Mendelian Inheritance in Man; RBC, red blood cell; SNP, single nucleotide polymorphism; SNV, single nucleotide variant; UNCS, unknown clinical significance.
Among gene variants associated with altered smooth muscle or nerve functions, the prime candidates of interest appear to be ANO1, CPI-17 (aka PPP1R14A), COLQ6, COL6A1, and CALCB or CALCA. Thus, ANO1 influences Ca2+-activated Cl- channels in the pacemaker ICCs, downregulation of CPI-17 causes sustained muscle contraction, and downregulation of COLQ reduces acetyl cholinesterase. P2RY12 and CALCB or CALCA affect afferent nerves, microglia, or calcium balance, and may indirectly affect neuromuscular function. Other genes, COL6A1, ARHGAP15, and S100A10, potentially impact the structure, tensile strength, or biomechanical properties of the colon. Despite their biological plausibility, the SNPs or SNVs themselves are mostly intronic and are of unclear clinical significance.
Because diverticular disease is a heterogeneous grouping, the relative genetic effect of 27 replicating loci on diverticulitis vs diverticulosis risk was assessed in the European cohort of the Schafmayer et al study. Four loci showed stronger effects for diverticulitis compared with diverticulosis (PHGR1, FAM155A-2, CALCB, and S100A10). Again, the gene CALCB is associated with afferent nerve function and calcium balance, which supports a role for dysmotility in diverticulitis pathogenesis. The gene S100A10 regulates the remodeling of the extracellular matrix, which also suggests dysmotility or potentially structural weakness in the diverticulum leading to diverticulitis. The gene PHGR1 may conceivably increase risk of diverticulitis as it causes epithelial dysfunction and could conceivably increase the likelihood of bacterial penetration to induce inflammation.
Of note, with rare exception (FADD) there was little overlap with genes associated with inflammatory bowel disease. Specifically, the genetic studies in diverticulosis and diverticulitis have not identified associations with HLA genes, or genes involved in regulation of innate or adaptive immune responses, defense responses, or responses to biotic stimuli or organisms, which have been described as factors determining susceptibility or outcome in patients with Crohn’s disease.79 Similarly, there was no overlap with 38 susceptibility loci for inflammatory bowel disease identified across populations.80
Diverticular hemorrhage is the result of an arterial rupture in the base or neck of a diverticulum. While less frequent than diverticulitis, cases of diverticular hemorrhage would have been captured under the umbrella of diverticula disease in the GWASs described here. There are several genes in the GWASs that could be implicated in the pathogenesis of diverticular hemorrhage. The genes ELN, BMPR1B, and EFEMP1 are associated with connective tissue function, and laxity in a diverticulum may predispose to shearing of the culprit artery. There are also several genes associated with vascular disease. The ABO gene encodes proteins related to the ABO blood group system. In addition to red blood cells, ABO carbohydrates are expressed on the surface of many tissues and cells, including epithelial cells, sensory neurons, platelets, and vascular epithelium, and are associated with risk of thrombosis and hemorrhage.81 ABO antigens and blood group type has been associated with risk of gastrointestinal bleeding.82 While P2RY12 has a role in neural development, this gene also has a role in platelet function, which may impact hemorrhage risk. CALCB has a role in vascular endothelium, SLC35F3 in hypertension, and CACNB2 in Ca (2+)-channel activity. If the hypothesis that vascular disease drives diverticulitis risk is true, these same genes may play a role in diverticulitis. However, the mechanism whereby a vascular mechanism results in diverticulosis is still unclear.
While the approach used in our appraisal of the genetic associations with diverticular disease have been based on prior biological knowledge, there are algorithms and tools for inferring and scoring regulator networks upstream of gene-expression data (eg, based on large-scale causal network derived from the Ingenuity Knowledge Base) or to predict downstream effects on biological functions and diseases, within Ingenuity Pathway Analysis (http://www.ingenuity.com). Thus, causal analytics tools are available to appraise upstream regulator analysis, mechanistic networks, causal network analysis, and downstream effects analysis.83 However, the pathway analysis is usually applied to tissue gene expression or transcriptomics and may identify tissue processes such as inflammation and immune response, cytokine signaling, cellular growth, and movement in addition to processes more directly related to specific functions such as nerve regeneration following nerve injury.84
Schafmayer et al85 used 2 gene set and pathway analysis approaches (MsigDB)86 and VEGAS2Pathway87 to determine if the polygenic signal measured in the diverticular disease associated genes clustered in specific biological pathways. VEGAS2Pathway analysis pointed to processes involved in cell and organ differentiation and extracellular matrix among the top 5 identified pathways: negative regulation of cell differentiation, extracellular matrix, negative regulation of developmental process, muscle organ development, and regulation of cell differentiation. These relatively nonspecific pathways contrast with the identified individual genes that affect neuromuscular mechanisms or connective tissue in the study by Schafmayer et al85 such as ANO1 (intestinal motility), COL6A1/A2 (connective tissue), and GDNF and BDNF (neurotrophic factors). These are all mechanisms that are plausibly related to the development of diverticular disease.
Future Research
This analysis provides insights into the genes and mechanisms that might be prioritized for further mechanistic, phenotypic measurements (eg, colonic diameter, transit, pressures, and compliance), as well as association studies with gene variants that are more closely aligned to colonic function. Such hypothesis-based research would require smaller sample size and should ascertain the contributions of abnormal motor physiology and genetics to the development and natural history of diverticular disease.
Acknowledgments
The authors thank Mrs Cindy Stanislav for excellent secretarial support.
Footnotes
Conflicts of interest The authors disclose no conflicts.
Funding This work was supported by National Institutes of Health grants R01DK115950 (to Michael Camilleri), P30-DK034987 (Robert S. Sandler), R01DK09473 (to Robert S. Sandler), and K23DK113225 (to Anne F. Peery).
References
- 1.Everhart J.E., Ruhl C.E. Burden of digestive diseases in the United States part II: lower gastrointestinal diseases. Gastroenterology. 2009;136:741–754. doi: 10.1053/j.gastro.2009.01.015. [DOI] [PubMed] [Google Scholar]
- 2.Peery A.F., Keku T.O., Martin C.F., Eluri S., Runge T., Galanko J.A., Sandler R.S. Distribution and characteristics of colonic diverticula in a United States screening population. Clin Gastroenterol Hepatol. 2016;14:980–985.e1. doi: 10.1016/j.cgh.2016.01.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Ye H., Losada M., West A.B. Diverticulosis coli: update on a "Western" disease. Adv Anat Pathol. 2005;12:74–80. doi: 10.1097/01.pap.0000155054.76119.dc. [DOI] [PubMed] [Google Scholar]
- 4.Sugihara K., Muto T., Morioka Y., Asano A., Yamamoto T. Diverticular disease of the colon in Japan. A review of 615 cases. Dis Colon Rectum. 1989;27:531–537. doi: 10.1007/BF02555517. [DOI] [PubMed] [Google Scholar]
- 5.Lohsiriwat V., Suthikeeree W. Pattern and distribution of colonic diverticulosis: Analysis of 2877 barium enemas in Thailand. World J Gastroenterol. 2013;19:8709–8713. doi: 10.3748/wjg.v19.i46.8709. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Tarao K., Sekino Y., Nonaka T., Iida H., Inamori M., Nakajima A., Maeda S., Natsumeda Y., Ikegami T., Ohshige K. Recent trends in colonic diverticulosis in Yokohama City: a possibility of changing to a more Western profile. Intern Med. 2015;54:2545–2550. doi: 10.2169/internalmedicine.54.4813. [DOI] [PubMed] [Google Scholar]
- 7.Shahedi K., Fuller G., Bolus R., Cohen E., Vu M., Shah R., Agarwal N., Kaneshiro M., Atia M., Sheen V., Kurzbard N., van Oijen M.G., Yen L., Hodgkins P., Erder M.H., Spiegel B. Long-term risk of acute diverticulitis among patients with incidental diverticulosis found during colonoscopy. Clin Gastroenterol Hepatol. 2013;11:1609–1613. doi: 10.1016/j.cgh.2013.06.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Peery A.F., Crockett S.D., Murphy C.C., Lund J.L., Dellon E.S., Williams J.L., Jensen E.T., Shaheen N.J., Barritt A.S., Lieber S.R., Kochar B., Barnes E.L., Fan Y.C., Pate V., Galanko J., Baron T.H., Sandler R.S. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology. 2019;156:254–272.e11. doi: 10.1053/j.gastro.2018.08.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Strate L.L., Peery A.F., Neumann I. American Gastroenterological Association Institute technical review on the management of acute diverticulitis. Gastroenterology. 2015;149:1950–1976.e12. doi: 10.1053/j.gastro.2015.10.001. [DOI] [PubMed] [Google Scholar]
- 10.van Dijk S.T., Daniels L., de Korte N., Stockmann H.B., Vrouenraets B.C., J Consten E.C., B van der Hoeven J.A., Faneyte I.F., W Dijkgraaf M.G., Boermeester M.A. Dutch Diverticular Disease (3D) Collaborative Study Group. Quality of life and persistent symptoms after uncomplicated acute diverticulitis. Dis Colon Rectum. 2019;62:608–614. doi: 10.1097/DCR.0000000000001361. [DOI] [PubMed] [Google Scholar]
- 11.Strate L.L., Modi R., Cohen E., Spiegel B.M. Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights. Am J Gastroenterol. 2012;107:1486–1493. doi: 10.1038/ajg.2012.194. [DOI] [PubMed] [Google Scholar]
- 12.Cohen E., Fuller G., Bolus R., Modi R., Vu M., Shahedi K., Shah R., Atia M., Kurzbard N., Sheen V., Agarwal N., Kaneshiro M., Yen L., Hodgkins P., Erder M.H., Spiegel B. Increased risk for irritable bowel syndrome after acute diverticulitis. Clin Gastroenterol Hepatol. 2013;11:1614–1619. doi: 10.1016/j.cgh.2013.03.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Strate L.L., Morris A.M. Epidemiology, pathophysiology, and treatment of diverticulitis. Gastroenterology. 2019;156:1282–1298.e1. doi: 10.1053/j.gastro.2018.12.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Wedel T., Barrenschee M., Lange C., Cossais F., Böttner M. Morphologic basis for developing diverticular disease, diverticulitis, and diverticular bleeding. Viszeralmedizin. 2015;31:76–82. doi: 10.1159/000381431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Scarpignato C., Barbara G., Lanas A., Strate L.L. Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017. Therap Adv Gastroenterol. 2018;11 doi: 10.1177/1756284818771305. 1756284818771305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Peery A.F., Keku T.O., Addamo C., McCoy A.N., Martin C.F., Galanko J.A., Sandler R.S. Colonic diverticula are not associated with mucosal inflammation or chronic gastrointestinal symptoms. Clin Gastroenterol Hepatol. 2018;16:884–891.e1. doi: 10.1016/j.cgh.2017.05.051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Järbrink-Sehgal M.E., Rassam L., Jasim A., Walker M.M., Talley N.J., Agréus L., Andreasson A., Schmidt P.T. Diverticulosis, symptoms and colonic inflammation: A population-based colonoscopy study. Am J Gastroenterol. 2019;114:500–510. doi: 10.14309/ajg.0000000000000113. [DOI] [PubMed] [Google Scholar]
- 18.Granlund J., Svensson T., Olén O., Hjern F., Pedersen N.L., Magnusson P.K., Schmidt P.T. The genetic influence on diverticular disease--a twin study. Aliment Pharmacol Ther. 2012;35:1103–1107. doi: 10.1111/j.1365-2036.2012.05069.x. [DOI] [PubMed] [Google Scholar]
- 19.Strate L.L., Erichsen R., Baron J.A., Mortensen J., Pedersen J.K., Riis A.H., Christensen K., Sørensen H.T. Heritability and familial aggregation of diverticular disease: a population-based study of twins and siblings. Gastroenterology. 2013;144:736–742.e1. doi: 10.1053/j.gastro.2012.12.030. quiz e14. [DOI] [PubMed] [Google Scholar]
- 20.Painter N.S., Burkitt D.P. Diverticular disease of the colon: a deficiency disease of Western civilization. Br Med J. 1971;2:450–454. doi: 10.1136/bmj.2.5759.450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Painter N.S., Truelove S.C., Ardran G.M., Tuckey M. Segmentation and the localization of intraluminal pressures in the human colon, with special reference to the pathogenesis of colonic diverticula. Gastroenterology. 1965;49:169–177. [PubMed] [Google Scholar]
- 22.Peery A.F., Sandler R.S., Ahnen D.J., Galanko J.A., Holm A.N., Shaukat A., Mott L.A., Barry E.L., Fried D.A., Baron J.A. Constipation and a low-fiber diet are not associated with diverticulosis. Clin Gastroenterol Hepatol. 2013;11:1622–1627. doi: 10.1016/j.cgh.2013.06.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Peery A.F., Barrett P.R., Park D., Rogers A.J., Galanko J.A., Martin C.F., Sandler R.S. A high-fiber diet does not protect against asymptomatic diverticulosis. Gastroenterology. 2012;142:266–272.e1. doi: 10.1053/j.gastro.2011.10.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Broad J.B., Wu Z., Clark T.G., Musson D., Jaung R., Arroll B., Bissett I.P., Connolly M.J. Diverticulosis and nine connective tissue disorders: epidemiological support for an association. Connect Tissue Res. 2019;60:389–398. doi: 10.1080/03008207.2019.1570169. [DOI] [PubMed] [Google Scholar]
- 25.Reichert M.C., Lammert F. The genetic epidemiology of diverticulosis and diverticular disease: Emerging evidence. United European Gastroenterol J. 2015;3:409–418. doi: 10.1177/2050640615576676. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Ford M.J., Camilleri M., Wiste J.A., Hanson R.B. Differences in colonic tone and phasic response to a meal in the transverse and sigmoid human colon. Gut. 1995;37:264–269. doi: 10.1136/gut.37.2.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Steadman C.J., Phillips S.F., Camilleri M., Haddad A.C., Hanson R.B. Variation of muscle tone in the human colon. Gastroenterology. 1991;101:373–381. doi: 10.1016/0016-5085(91)90014-c. [DOI] [PubMed] [Google Scholar]
- 28.Mimura T., Bateman A.C., Lee R.L., Johnson P.A., McDonald P.J., Talbot I.C., Kamm M.A., MacDonald T.T., Pender S.L. Up-regulation of collagen and tissue inhibitors of matrix metalloproteinase in colonic diverticular disease. Dis Colon Rectum. 2004;47:371–378. doi: 10.1007/s10350-003-0050-5. discussion 378–379. [DOI] [PubMed] [Google Scholar]
- 29.Pantaroto M., Lopes Filho Gde J., Pinto C.A., Antico Filho A. Comparative study of collagen deposition in the colon wall of patients operated for sigmoid diverticular disease. Acta Cir Bras. 2015;30:715–719. doi: 10.1590/S0102-865020150100000010. [DOI] [PubMed] [Google Scholar]
- 30.Stumpf M., Cao W., Klinge U., Klosterhalfen B., Kasperk R., Schumpelick V. Increased distribution of collagen type III and reduced expression of matrix metalloproteinase 1 in patients with diverticular disease. Int J Colorectal Dis. 2001;16:271–275. doi: 10.1007/s003840100310. [DOI] [PubMed] [Google Scholar]
- 31.Wess L., Eastwood M.A., Wess T.J., Busuttil A., Miller A. Cross linking of collagen is increased in colonic diverticulosis. Gut. 1995;37:91–94. doi: 10.1136/gut.37.1.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Thomson H.J., Busuttil A., Eastwood M.A., Smith A.N., Elton R.A. Submucosal collagen changes in the normal colon and in diverticular disease. Int J Colorectal Dis. 1987;2:208–213. doi: 10.1007/BF01649507. [DOI] [PubMed] [Google Scholar]
- 33.Hellwig I., Böttner M., Barrenschee M., Harde J., Egberts J.H., Becker T., Wedel T. Alterations of the enteric smooth musculature in diverticular disease. J Gastroenterol. 2014;49:1241–1252. doi: 10.1007/s00535-013-0886-y. [DOI] [PubMed] [Google Scholar]
- 34.Altadill A., Eiró N., González L.O., Junquera S., González-Quintana J.M., Sánchez M.R., Andicoechea A., Saro C., Rodrigo L., Vizoso F.J. Comparative analysis of the expression of metalloproteases and their inhibitors in resected crohn's disease and complicated diverticular disease. Inflamm Bowel Dis. 2012;18:120–130. doi: 10.1002/ibd.21682. [DOI] [PubMed] [Google Scholar]
- 35.Bode M.K., Karttunen T.J., Mäkelä J., Risteli L., Risteli J. Type I and III collagens in human colon cancer and diverticulosis. Scand J Gastroenterol. 2000;35:747–752. doi: 10.1080/003655200750023435. [DOI] [PubMed] [Google Scholar]
- 36.Peery A.F., Keil A., Jicha K., Galanko J.A., Sandler R.S. Association of obesity with colonic diverticulosis in women. Clin Gastroenterol Hepatol. 2019 May 8 doi: 10.1016/j.cgh.2019.04.058. [E-pub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Kanda N., Watanabe S. Regulatory roles of sex hormones in cutaneous biology and immunology. J Dermatol Sci. 2005;38:1–7. doi: 10.1016/j.jdermsci.2004.10.011. [DOI] [PubMed] [Google Scholar]
- 38.Leblanc D.R., Schneider M., Angele P., Vollmer G., Docheva D. The effect of estrogen on tendon and ligament metabolism and function. J Steroid Biochem Mol Biol. 2017;172:106–116. doi: 10.1016/j.jsbmb.2017.06.008. [DOI] [PubMed] [Google Scholar]
- 39.Tworoger S.S., Eliassen A.H., Missmer S.A., Baer H., Rich-Edwards J., Michels K.B., Barbieri R.L., Dowsett M., Hankinson S.E. Birthweight and body size throughout life in relation to sex hormones and prolactin concentrations in premenopausal women. Cancer Epidemiol Biomarkers Prev. 2006;15:2494–2501. doi: 10.1158/1055-9965.EPI-06-0671. [DOI] [PubMed] [Google Scholar]
- 40.Jones R.B., Fodor A.A., Peery A.F., Tsilimigras M.C.B., Winglee K., McCoy A., Sioda M., Sandler R.S., Keku T.O. An aberrant microbiota is not strongly associated with incidental colonic diverticulosis. Sci Rep. 2018;8:4951. doi: 10.1038/s41598-018-23023-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Gallego D., Espín F., Mikulka J., Šmirg O., Gil V., Faundez-Zanuy M., Jiménez M., Clavé P. In vitro motor patterns and electrophysiological changes in patients with colonic diverticular disease. Int J Colorectal Dis. 2013;28:1413–1422. doi: 10.1007/s00384-013-1716-7. [DOI] [PubMed] [Google Scholar]
- 42.Mattii L., Ippolito C., Segnani C., Battolla B., Colucci R., Dolfi A., Bassotti G., Blandizzi C., Bernardini N. Altered expression pattern of molecular factors involved in colonic smooth muscle functions: an immunohistochemical study in patients with diverticular disease. PLoS One. 2013;8 doi: 10.1371/journal.pone.0057023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Böttner M., Barrenschee M., Hellwig I., Harde J., Egberts J.H., Becker T., Zorenkov D., Wedel T. The enteric serotonergic system is altered in patients with diverticular disease. Gut. 2013;62:1753–1762. doi: 10.1136/gutjnl-2012-302660. [DOI] [PubMed] [Google Scholar]
- 44.Bassotti G., Battaglia E., De Roberto G., Morelli A., Tonini M., Villanacci V. Alterations in colonic motility and relationship to pain in colonic diverticulosis. Clin Gastroenterol Hepatol. 2005;3:248–253. doi: 10.1016/s1542-3565(04)00614-7. [DOI] [PubMed] [Google Scholar]
- 45.Liu P.H., Cao Y., Keeley B.R., Tam I., Wu K., Strate L.L., Giovannucci E.L., Chan A.T. Adherence to a healthy lifestyle is associated with a lower risk of diverticulitis among men. Am J Gastroenterol. 2017;112:1868–1876. doi: 10.1038/ajg.2017.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Bharucha A.E., Parthasarathy G., Ditah I., Fletcher J.G., Ewelukwa O., Pendlimari R., Yawn B.P., Melton L.J., Schleck C., Zinsmeister A.R. Temporal trends in the incidence and natural history of diverticulitis: a population-based study. Am J Gastroenterol. 2015;110:1589–1596. doi: 10.1038/ajg.2015.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Jovani M., Ma W., Joshi A.D., Liu P.H., Nguyen L.H., Cao Y., Tam I., Wu K., Giovannucci E.L., Chan A.T., Strate L.L. Menopausal hormone therapy and risk of diverticulitis. Am J Gastroenterol. 2019;114:315–321. doi: 10.14309/ajg.0000000000000054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Ma W., Jovani M., Liu P.H., Nguyen L.H., Cao Y., Tam I., Wu K., Giovannucci E.L., Strate L.L., Chan A.T. Association between obesity and weight change and risk of diverticulitis in women. Gastroenterology. 2018;155:58–66.e4. doi: 10.1053/j.gastro.2018.03.057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Cao Y., Strate L.L., Keeley B.R., Tam I., Wu K., Giovannucci E.L., Chan A.T. Meat intake and risk of diverticulitis among men. Gut. 2018;67:466–472. doi: 10.1136/gutjnl-2016-313082. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Strate L.L., Keeley B.R., Cao Y., Wu K., Giovannucci E.L., Chan A.T. Western dietary pattern increases, and prudent dietary pattern decreases, risk of incident diverticulitis in a prospective cohort study. Gastroenterology. 2017;152:1023–1030.e2. doi: 10.1053/j.gastro.2016.12.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Strate L.L., Liu Y.L., Aldoori W.H., Giovannucci E.L. Physical activity decreases diverticular complications. Am J Gastroenterol. 2009;104:1221–1230. doi: 10.1038/ajg.2009.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Strate L.L., Liu Y.L., Aldoori W.H., Syngal S., Giovannucci E.L. Obesity increases the risks of diverticulitis and diverticular bleeding. Gastroenterology. 2009;136:115–122.e1. doi: 10.1053/j.gastro.2008.09.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Strate L.L., Liu Y.L., Huang E.S., Giovannucci E.L., Chan A.T. Use of aspirin or nonsteroidal anti-inflammatory drugs increases risk for diverticulitis and diverticular bleeding. Gastroenterology. 2011;140:1427–1433. doi: 10.1053/j.gastro.2011.02.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Sachar D.B., NDSG Diverticulitis in immunosuppressed patients. J Clin Gastroenterol. 2008;42:1154–1155. doi: 10.1097/MCG.0b013e3181862ac1. [DOI] [PubMed] [Google Scholar]
- 55.Young-Fadok T.M. Diverticulitis. N Engl J Med. 2019;380:500–501. doi: 10.1056/NEJMc1815667. [DOI] [PubMed] [Google Scholar]
- 56.Jovani M., Ma W., Staller K., Joshi A.D., Cao Y., Nguyen L.H., Liu P.-H., Tam I., Wu K., Chan A.T., Strate L.L. Association between bowel movements and diverticulitis in women. Gastroenterology. 2019;156(Suppl 1):S1069. [Google Scholar]
- 57.Wedel T., Büsing V., Heinrichs G., Nohroudi K., Bruch H.P., Roblick U.J., Böttner M. Diverticular disease is associated with an enteric neuropathy as revealed by morphometric analysis. Neurogastroenterol Motil. 2010;22:407–414. doi: 10.1111/j.1365-2982.2009.01445.x. e93–94. [DOI] [PubMed] [Google Scholar]
- 58.Barrenschee M., Wedel T., Lange C., Hohmeier I., Cossais F., Ebsen M., Vogel I., Böttner M. No neuronal loss, but alterations of the GDNF system in asymptomatic diverticulosis. PLoS One. 2017;12 doi: 10.1371/journal.pone.0171416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Golder M., Burleigh D.E., Ghali L., Feakins R.M., Lunniss P.J., Williams N.S., Navsaria H.A. Longitudinal muscle shows abnormal relaxation responses to nitric oxide and contains altered levels of NOS1 and elastin in uncomplicated diverticular disease. Colorectal Dis. 2007;9:218–228. doi: 10.1111/j.1463-1318.2006.01160.x. [DOI] [PubMed] [Google Scholar]
- 60.Coble J.L., Sheldon K.E., Yue F., Salameh T.J., Harris L.R., III, Deiling S., Ruggiero F.M., Eshelman M.A., Yochum G.S., Koltun W.A., Gerhard G.S., Broach J.R. Identification of a rare LAMB4 variant associated with familial diverticulitis through exome sequencing. Hum Mol Genet. 2017;26:3212–3220. doi: 10.1093/hmg/ddx204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Rosemar A., Ivarsson M.L., Börjesson L., Holmdahl L. Increased concentration of tissue-degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease. Scand J Gastroenterol. 2007;42:215–220. doi: 10.1080/00365520600960104. [DOI] [PubMed] [Google Scholar]
- 62.Whiteway J., Morson B.C. Elastosis in diverticular disease of the sigmoid colon. Gut. 1985;26:258–266. doi: 10.1136/gut.26.3.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Daniels L., Philipszoon L.E., Boermeester M.A. A hypothesis: important role for gut microbiota in the etiopathogenesis of diverticular disease. Dis Colon Rectum. 2014;57:539–543. doi: 10.1097/DCR.0000000000000078. [DOI] [PubMed] [Google Scholar]
- 64.Nguyen L.H., Cao Y., Ma W., Jovani M., Liu P.-H., Huttenhower C., Ludvigsson J.F., Wu K., Giovannucci E., Strate L.L., Chan A.T. Chronic antibiotic use and subsequent development of diverticulitis. Gastroenterology. 2019;156(Suppl 1):S1155. [Google Scholar]
- 65.Gueimonde M., Ouwehand A., Huhtinen H., Salminen E., Salminen S. Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease. World J Gastroenterol. 2007;13:3985–3989. doi: 10.3748/wjg.v13.i29.3985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Daniels L., Budding A.E., de Korte N., Eck A., Bogaards J.A., Stockmann H.B., Consten E.C., Savelkoul P.H., Boermeester M.A. Fecal microbiome analysis as a diagnostic test for diverticulitis. Eur J Clin Microbiol Infect Dis. 2014;33:1927–1936. doi: 10.1007/s10096-014-2162-3. [DOI] [PubMed] [Google Scholar]
- 67.Hullar M.A., Sandstrom R., Stamatoyannopoulos J.A., Lampe J.W., Strate L.L. The fecal microbiome in diverticulitis and uncomplicated diverticulosis. Gastroenterology. 2014;146(Suppl 1):S45. [Google Scholar]
- 68.Hullar M.A., Sandstrom R., Lampe J.W., Strate L.L. The fecal microbiome differentiates patients with a history of diverticulitis v. those with uncomplicated diverticulosis. Gastroenterology. 2017;152(Suppl 1):S624. [Google Scholar]
- 69.Humes D.J., Fleming K.M., Spiller R.C., West J. Concurrent drug use and the risk of perforated colonic diverticular disease: a population-based case-control study. Gut. 2011;60:219–224. doi: 10.1136/gut.2010.217281. [DOI] [PubMed] [Google Scholar]
- 70.Ma W., Jovani M., Nguyen L.H., Song M., Liu P.-H., Cao Y., Tam I., Wu K., Giovannucci E., Strate L.L., Chan A.T. Inflammatory potential of diet, circulating inflammatory markers, and risk of diverticulitis. Gastroenterology. 2019;156(Suppl 1):S1056. [Google Scholar]
- 71.Strate L.L., Erichsen R., Horváth-Puhó E., Pedersen L., Baron J.A., Sørensen H.T. Diverticular disease is associated with increased risk of subsequent arterial and venous thromboembolic events. Clin Gastroenterol Hepatol. 2014;12:1695–1701.e1. doi: 10.1016/j.cgh.2013.11.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Strate L.L., Gralnek I.M. ACG clinical guideline: Management of patients with acute lower gastrointestinal bleeding. Am J Gastroenterol. 2016;111:755. doi: 10.1038/ajg.2016.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Wheat C.L., Strate L.L. Trends in hospitalization for diverticulitis and diverticular bleeding in the United States from 2000 to 2010. Clin Gastroenterol Hepatol. 2016;14:96–103.e1. doi: 10.1016/j.cgh.2015.03.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Okamoto T., Watabe H., Yamada A., Hirata Y., Yoshida H., Koike K. The association between arteriosclerosis related diseases and diverticular bleeding. Int J Colorectal Dis. 2012;27:1161–1166. doi: 10.1007/s00384-012-1491-x. [DOI] [PubMed] [Google Scholar]
- 75.Yuhara H., Corley D.A., Nakahara F., Nakajima T., Koike J., Igarashi M., Suauki T., Mine T. Aspirin and non-aspirin NSAIDs increase risk of colonic diverticular bleeding: a systematic review and meta-analysis. J Gastroenterol. 2014;49:992–1000. doi: 10.1007/s00535-013-0905-z. [DOI] [PubMed] [Google Scholar]
- 76.Vajravelu R.K., Mamtani R., Scott F.I., Waxman A., Lewis J.D. Incidence, risk factors, and clinical effects of recurrent diverticular hemorrhage: a large cohort study. Gastroenterology. 2018;155:1416–1427. doi: 10.1053/j.gastro.2018.07.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Edwards R.A., Lutz P.L., Baden D.G. Relationship between energy expenditure and ion channel density in the turtle and rat brain. Am J Physiol. 1989;257:R1354–R1358. doi: 10.1152/ajpregu.1989.257.6.R1354. [DOI] [PubMed] [Google Scholar]
- 78.Connelly T.M., Choi C.S., Berg A.S., Harris L., 3rd, Coble J., Koltun W.A. Diverticulitis and Crohn's disease have distinct but overlapping tumor necrosis superfamily 15 haplotypes. J Surg Res. 2017;214:262–269. doi: 10.1016/j.jss.2017.02.030. [DOI] [PubMed] [Google Scholar]
- 79.Lee J.C., Biasci D., Roberts R., Gearry R.B., Mansfield J.C., Ahmad T., Prescott N.J., Satsangi J., Wilson D.C., Jostins L., Anderson C.A., UK IBD Genetics Consortium. Traherne J.A., Lyons P.A., Parkes M., Smith K.G. Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease. Nat Genet. 2017;49:262–268. doi: 10.1038/ng.3755. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Liu J.Z., van Sommeren S., Huang H., Ng S.C., Alberts R., Takahashi A., Ripke S., Lee J.C., Jostins L., Shah T., Abedian S., Cheon J.H., Cho J., Dayani N.E., Franke L., Fuyuno Y., Hart A., Juyal R.C., Juyal G., Kim W.H., Morris A.P., Poustchi H., Newman W.G., Midha V., Orchard T.R., Vahedi H., Sood A., Sung J.Y., Malekzadeh R., Westra H.J., Yamazaki K., Yang S.K., International Multiple Sclerosis Genetics Consortium. International IBD Genetics Consortium. Barrett J.C., Alizadeh B.Z., Parkes M., Bk T., Daly M.J., Kubo M., Anderson CA, Weersma RK. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47:979–986. doi: 10.1038/ng.3359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Franchini M., Lippi G. Relative risks of thrombosis and bleeding in different ABO blood groups. Semin Thromb Hemost. 2016;42:112–117. doi: 10.1055/s-0035-1564832. [DOI] [PubMed] [Google Scholar]
- 82.Huang E.S., Khalili H., Strate L.L., Chan A.T. ABO blood group and the risk of gastrointestinal bleeding. Gastroenterology. 2012;142(Suppl 1):S503. [Google Scholar]
- 83.Krämer A., Green J., Pollard J., Jr., Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2014;30:523–530. doi: 10.1093/bioinformatics/btt703. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Yu J., Gu X., Yi S. Ingenuity Pathway Analysis of gene expression profiles in distal nerve stump following nerve injury: Insights into Wallerian Degeneration. Front Cell Neurosci. 2016;10:274. doi: 10.3389/fncel.2016.00274. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Schafmayer C., Harrison J.W., Buch S., Lange C., Reichert M.C., Hofer P., Cossais F., Kupcinskas J., von Schönfels W., Schniewind B., Kruis W., Tepel J., Zobel M., Rosendahl J., Jacobi T., Walther-Berends A., Schroeder M., Vogel I., Sergeev P., Boedeker H., Hinrichsen H., Volk A., Erk J.U., Burmeister G., Hendricks A., Hinz S., Wolff S., Böttner M., Wood A.R., Tyrrell J., Beaumont R.N., Langheinrich M., Kucharzik T., Brezina S., Huber-Schönauer U., Pietsch L., Noack L.S., Brosch M., Herrmann A., Thangapandi R.V., Schimming H.W., Zeissig S., Palm S., Focke G., Andreasson A., Schmidt P.T., Weitz J., Krawczak M., Völzke H., Leeb G., Michl P., Lieb W., Grützmann R., Franke A., Lammert F., Becker T., Kupcinskas L., D'Amato M., Wedel T., Datz C., Gsur A., Weedon M.N., Hampe J. Genome-wide association analysis of diverticular disease points towards neuromuscular, connective tissue and epithelial pathomechanisms. Gut. 2019;68:854–865. doi: 10.1136/gutjnl-2018-317619. [DOI] [PubMed] [Google Scholar]
- 86.Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545–15550. doi: 10.1073/pnas.0506580102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Mishra A., MacGregor S. A novel approach for pathway analysis of GWAS data highlights role of BMP signaling and muscle cell differentiation in colorectal cancer susceptibility. Twin Res Hum Genet. 2017;20:1–9. doi: 10.1017/thg.2016.100. [DOI] [PubMed] [Google Scholar]
- 88.Sigurdsson S., Alexandersson K.F., Sulem P., Feenstra B., Gudmundsdottir S., Halldorsson G.H., Olafsson S., Sigurdsson A., Rafnar T., Thorgeirsson T., Sørensen E., Nordholm-Carstensen A., Burcharth J., Andersen J., Jørgensen H.S., Possfelt-Møller E., Ullum H., Thorleifsson G., Masson G., Thorsteinsdottir U., Melbye M., Gudbjartsson D.F., Stefansson T., Jonsdottir I., Stefansson K. Sequence variants in ARHGAP15, COLQ and FAM155A associate with diverticular disease and diverticulitis. Nat Commun. 2017;8:15789. doi: 10.1038/ncomms15789. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Maguire L.H., Handelman S.K., Du X., Chen Y., Pers T.H., Speliotes E.K. Genome-wide association analyses identify 39 new susceptibility loci for diverticular disease. Nat Genet. 2018;50:1359–1365. doi: 10.1038/s41588-018-0203-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Coyle D., Kelly D.A., O'Donnell A.M., Gillick J., Puri P. Use of anoctamin 1 (ANO1) to evaluate interstitial cells of Cajal in Hirschsprung's disease. Pediatr Surg Int. 2016;32:125–133. doi: 10.1007/s00383-015-3822-9. [DOI] [PubMed] [Google Scholar]
- 91.Tang T., Chen Q., Ma C., Ni L., Jiang J., Li N. Expression of TMEM16A in the colon of intractable functional constipation patients and its clinical implications. Zhonghua Wei Chang Wai Ke Za Zhi. 2015;18:713–717. [PubMed] [Google Scholar]
- 92.Gomez-Pinilla P.J., Gibbons S.J., Bardsley M.R., Lorincz A., Pozo M.J., Pasricha P.J., Van de Rijn M., West R.B., Sarr M.G., Kendrick M.L., Cima R.R., Dozois E.J., Larson D.W., Ordog T., Farrugia G. Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol. 2009;296:G1370–G1381. doi: 10.1152/ajpgi.00074.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Smigiel R., Szafranska A., Czyzewska M., Rauch A., Zweier Ch, Patkowski D. Severe clinical course of Hirschsprung disease in a Mowat-Wilson syndrome patient. J Appl Genet. 2010;51:111–113. doi: 10.1007/BF03195718. [DOI] [PubMed] [Google Scholar]
- 94.Costa C., Germena G., Martin-Conte E.L., Molineris I., Bosco E., Marengo S., Azzolino O., Altruda F., Ranieri V.M., Hirsch E. The RacGAP ArhGAP15 is a master negative regulator of neutrophil functions. Blood. 2011;118:1099–1108. doi: 10.1182/blood-2010-12-324756. [DOI] [PubMed] [Google Scholar]
- 95.Zamboni V., Armentano M., Sarò G., Ciraolo E., Ghigo A., Germena G., Umbach A., Valnegri P., Passafaro M., Carabelli V., Gavello D., Bianchi V., D'Adamo P., de Curtis I., El-Assawi N., Mauro A., Priano L., Ferri N., Hirsch E., Merlo G.R. Disruption of ArhGAP15 results in hyperactive Rac1, affects the architecture and function of hippocampal inhibitory neurons and causes cognitive deficits. Sci Rep. 2016;6:34877. doi: 10.1038/srep34877. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Radu M., Rawat S.J., Beeser A., Iliuk A., Tao W.A., Chernoff J. ArhGAP15, a Rac-specific GTPase-activating protein, plays a dual role in inhibiting small GTPase signaling. J Biol Chem. 2013;288:21117–21125. doi: 10.1074/jbc.M113.459719. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Seoh M.L., Ng C.H., Yong J., Lim L., Leung T. ArhGAP15, a novel human RacGAP protein with GTPase binding property. FEBS Lett. 2003;539:131–137. doi: 10.1016/s0014-5793(03)00213-8. [DOI] [PubMed] [Google Scholar]
- 98.Sigoillot S.M., Bourgeois F., Lambergeon M., Strochlic L., Legay C. ColQ controls postsynaptic differentiation at the neuromuscular junction. J Neurosci. 2010;30:13–23. doi: 10.1523/JNEUROSCI.4374-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.GTEx Consortium Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science. 2015;348:648–660. doi: 10.1126/science.1262110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Engel A.G., Shen X.M., Selcen D., Sine S.M. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol. 2015;14:420–434. doi: 10.1016/S1474-4422(14)70201-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Ohno K., Brengman J., Tsujino A., Engel A.G. Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme. Proc Natl Acad Sci U S A. 1998;95:9654–9659. doi: 10.1073/pnas.95.16.9654. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Mori D., Hori M., Murata T., Ohama T., Kishi H., Kobayashi S., Ozaki H. Synchronous phosphorylation of CPI–17 and MYPT1 is essential for inducing Ca(2+) sensitization in intestinal smooth muscle. Neurogastroenterol Motil. 2011;23:1111–1122. doi: 10.1111/j.1365-2982.2011.01799.x. [DOI] [PubMed] [Google Scholar]
- 103.Hu W., Mahavadi S., Li F., Murthy K.S. Upregulation of RGS4 and downregulation of CPI–17 mediate inhibition of colonic muscle contraction by interleukin-1beta. Am J Physiol Cell Physiol. 2007;293:C1991–C2000. doi: 10.1152/ajpcell.00300.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Somara S., Gilmont R.R., Martens J.R., Bitar K.N. Ectopic expression of caveolin-1 restores physiological contractile response of aged colonic smooth muscle. Am J Physiol Gastrointest Liver Physiol. 2007;293:G240–G249. doi: 10.1152/ajpgi.00064.2007. [DOI] [PubMed] [Google Scholar]
- 105.Li J.L., Fu Y., Qin S.B., Liang G.K., Liu J., Nie X.Y., Chen J., Shi L.W., Shao H., Lu Y. Association between P2RY12 gene polymorphisms and adverse clinical events in coronary artery disease patients treated with clopidogrel: a systematic review and meta-analysis. Gene. 2018;657:69–80. doi: 10.1016/j.gene.2018.03.007. [DOI] [PubMed] [Google Scholar]
- 106.von Kügelgen I. Structure, pharmacology and roles in physiology of the P2Y12 receptor. Adv Exp Med Biol. 2017;1051:123–138. doi: 10.1007/5584_2017_98. [DOI] [PubMed] [Google Scholar]
- 107.Chauhan M., Yallampalli U., Banadakappa M., Yallampalli C. Involvement of receptor activity-modifying protein 3 (RAMP3) in the vascular actions of adrenomedullin in rat mesenteric artery smooth muscle cells. Biol Reprod. 2015;93:116. doi: 10.1095/biolreprod.115.134585. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Wang P., Liu X., Zhu B., Ma Y., Yong L., Teng Z., Liang C., He G., Liu X. Association of IL17RC and COL6A1 genetic polymorphisms with susceptibility to ossification of the thoracic posterior longitudinal ligament in Chinese patients. J Orthop Surg Res. 2018;13:109. doi: 10.1186/s13018-018-0817-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Butterfield R.J., Dunn D.M., Hu Y., Johnson K., Bönnemann C.G., Weiss R.B. Transcriptome profiling identifies regulators of pathogenesis in collagen VI related muscular dystrophy. PLoS One. 2017;12 doi: 10.1371/journal.pone.0189664. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Cescon M., Chen P., Castagnaro S., Gregorio I., Bonaldo P. Lack of collagen VI promotes neurodegeneration by impairing autophagy and inducing apoptosis during aging. Aging (Albany NY) 2016;8:1083–1101. doi: 10.18632/aging.100924. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Chen P., Cescon M., Megighian A., Bonaldo P. Collagen VI regulates peripheral nerve myelination and function. FASEB J. 2014;28:1145–1156. doi: 10.1096/fj.13-239533. [DOI] [PubMed] [Google Scholar]
- 112.Soret R., Mennetrey M., Bergeron K.F., Dariel A., Neunlist M., Grunder F., Faure C., Silversides D.W., Pilon N., Ente-Hirsch Study Group A collagen VI-dependent pathogenic mechanism for Hirschsprung's disease. J Clin Invest. 2015;125:4483–4496. doi: 10.1172/JCI83178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Bönnemann C.G. The collagen VI-related myopathies: muscle meets its matrix. Nat Rev Neurol. 2011;7:379–390. doi: 10.1038/nrneurol.2011.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Cescon M., Gregorio I., Eiber N., Borgia D., Fusto A., Sabatelli P., Scorzeto M., Megighian A., Pegoraro E., Hashemolhosseini S., Bonaldo P. Collagen VI is required for the structural and functional integrity of the neuromuscular junction. Acta Neuropathol. 2018;136:483–499. doi: 10.1007/s00401-018-1860-9. [DOI] [PubMed] [Google Scholar]
- 115.Oltedal S., Skaland I., Maple-Grødem J., Tjensvoll K., Janssen E.A.M., Gilje B., Smaaland R., Heikkilä R., Nordgård O. Expression profiling and intracellular localization studies of the novel proline-, histidine-, and glycine-rich protein 1 suggest an essential role in gastro-intestinal epithelium and a potential clinical application in colorectal cancer diagnostics. BMC Gastroenterol. 2018;18:26. doi: 10.1186/s12876-018-0752-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Yamamoto F. Review: ABO blood group system--ABH oligosaccharide antigens, anti-A and anti-B, A and B glycosyltransferases, and ABO genes. Immunohematology. 2004;20:3–22. [PubMed] [Google Scholar]
- 117.Madureira P.A., O'Connell P.A., Surette A.P., Miller V.A., Waisman D.M. The biochemistry and regulation of S100A10: a multifunctional plasminogen receptor involved in oncogenesis. J Biomed Biotechnol. 2012;2012:353687. doi: 10.1155/2012/353687. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Zhao Y., Zhang M., Liu H., Wang J. Signaling by growth/differentiation factor 5 through the bone morphogenetic protein receptor type IB protects neurons against kainic acid-induced neurodegeneration. Neurosci Lett. 2017;651:36–42. doi: 10.1016/j.neulet.2017.04.055. [DOI] [PubMed] [Google Scholar]
- 119.Racacho L., Byrnes A.M., MacDonald H., Dranse H.J., Nikkel S.M., Allanson J., Rosser E., Underhill T.M., Bulman D.E. Two novel disease-causing variants in BMPR1B are associated with brachydactyly type A1. Eur J Hum Genet. 2015;23:1640–1645. doi: 10.1038/ejhg.2015.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Wiberg A., Ng M., Schmid A.B., Smillie R.W., Baskozos G., Holmes M.V., Künnapuu K., Mägi R., Bennett D.L., Furniss D. A genome-wide association analysis identifies 16 novel susceptibility loci for carpal tunnel syndrome. Nat Commun. 2019;10:1030. doi: 10.1038/s41467-019-08993-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Zhang K., Huentelman M.J., Rao F., Sun E.I., Corneveaux J.J., Schork A.J., Wei Z., Waalen J., Miramontes-Gonzalez J.P., Hightower C.M., Maihofer A.X., Mahata M., Pastinen T., Ehret G.B., International Consortium for Blood Pressure Genome-Wide Association Studies. Schork N.J., Eskin E., Nievergelt C.M., Saier M.H., Jr., O'Connor D.T. Genetic implication of a novel thiamine transporter in human hypertension. J Am Coll Cardiol. 2014;63:1542–1555. doi: 10.1016/j.jacc.2014.01.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Khrimian L., Obri A., Ramos-Brossier M., Rousseaud A., Moriceau S., Nicot A.S., Mera P., Kosmidis S., Karnavas T., Saudou F., Gao X.B., Oury F., Kandel E., Karsenty G. Gpr158 mediates osteocalcin's regulation of cognition. J Exp Med. 2017;214:2859–2873. doi: 10.1084/jem.20171320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Piaggi P., Masindova I., Muller Y.L., Mercader J., Wiessner G.B., Chen P., SIGMA Type 2 Diabetes Consortium. Kobes S., Hsueh W.C., Mongalo M., Knowler W.C., Krakoff J., Hanson R.L., Bogardus C., Baier L.J. A genome-wide association study using a custom genotyping array identifies variants in GPR158 associated with reduced energy expenditure in American Indians. Diabetes. 2017;66:2284–2295. doi: 10.2337/db16-1565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Ge X., Yamamoto S., Tsutsumi S., Midorikawa Y., Ihara S., Wang S.M., Aburatani H. Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics. 2005;86:127–141. doi: 10.1016/j.ygeno.2005.04.008. [DOI] [PubMed] [Google Scholar]
- 125.Su A.I., Wiltshire T., Batalov S., Lapp H., Ching K.A., Block D., Zhang J., Soden R., Hayakawa M., Kreiman G., Cooke M.P., Walker J.R., Hogenesch J.B. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A. 2004;101:6062–6067. doi: 10.1073/pnas.0400782101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126.Boraxbekk C.J., Ames D., Kochan N.A., Lee T., Thalamuthu A., Wen W., Armstrong N.J., Kwok J.B., Schofield P.R., Reppermund S., Wright M.J., Trollor J.N., Brodaty H., Sachdev P., Mather K.A. Investigating the influence of KIBRA and CLSTN2 genetic polymorphisms on cross-sectional and longitudinal measures of memory performance and hippocampal volume in older individuals. Neuropsychologia. 2015;78:10–17. doi: 10.1016/j.neuropsychologia.2015.09.031. [DOI] [PubMed] [Google Scholar]
- 127.de Ramon Francàs G., Alther T., Stoeckli E.T. Calsyntenins are expressed in a dynamic and partially overlapping manner during neural development. Front Neuroanat. 2017;11:76. doi: 10.3389/fnana.2017.00076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128.Rasmussen M.B., Kreiborg S., Jensen P., Bak M., Mang Y., Lodahl M., Budtz-Jørgensen E., Tommerup N., Tranebjærg L., Rendtorff N.D. Phenotypic subregions within the split-hand/foot malformation 1 locus. Hum Genet. 2016;135:345–357. doi: 10.1007/s00439-016-1635-0. [DOI] [PubMed] [Google Scholar]
- 129.Usener D., Schadendorf D., Koch J., Dübel S., Eichmüller S. cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing. J Invest Dermatol. 2003;121:198–206. doi: 10.1046/j.1523-1747.2003.12318.x. [DOI] [PubMed] [Google Scholar]
- 130.Schellhaus A.K., Moreno-Andrés D., Chugh M., Yokoyama H., Moschopoulou A., De S., Bono F., Hipp K., Schäffer E., Antonin W. Developmentally regulated GTP binding protein 1 (DRG1) controls microtubule dynamics. Sci Rep. 2017;7:9996. doi: 10.1038/s41598-017-10088-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131.Lee H., Kim M., Kim N., Macfarlan T., Pfaff S.L., Mastick G.S., Song M.R. Slit and Semaphorin signaling governed by islet transcription factors positions motor neuron somata within the neural tube. Exp Neurol. 2015;269:17–27. doi: 10.1016/j.expneurol.2015.03.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132.Wang N., Deng Z., Wang M., Li R., Xu G., Bao G. Additional evidence supports association of common genetic variants in VTI1A and ETFA with increased risk of glioma susceptibility. J Neurol Sci. 2017;375:282–288. doi: 10.1016/j.jns.2017.02.013. [DOI] [PubMed] [Google Scholar]
- 133.Edwards T.L., Hartmann K.E., Velez Edwards D.R. Variants in BET1L and TNRC6B associate with increasing fibroid volume and fibroid type among European Americans. Hum Genet. 2013;132:1361–1369. doi: 10.1007/s00439-013-1340-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Lin Y.J., Chang J.S., Liu X., Lin T.H., Huang S.M., Liao C.C., Lin C.W., Chien W.K., Chen J.H., Wu J.Y., Chen C.H., Chang L.C., Tsang H., Jeang K.T., Chen C.Y., Tsai F.J. Sorting nexin 24 genetic variation associates with coronary artery aneurysm severity in Kawasaki disease patients. Cell Biosci. 2013;3:44. doi: 10.1186/2045-3701-3-44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135.Rohrbach S., Aurich A.C., Li L., Niemann B. Age-associated loss in adiponectin-activation by caloric restriction: lack of compensation by enhanced inducibility of adiponectin paralogs CTRP2 and CTRP7. Mol Cell Endocrinol. 2007;277:26–34. doi: 10.1016/j.mce.2007.07.005. [DOI] [PubMed] [Google Scholar]
- 136.Dick D.M., Aliev F., Krueger R.F., Edwards A., Agrawal A., Lynskey M., Lin P., Schuckit M., Hesselbrock V., Nurnberger J., Jr., Almasy L., Porjesz B., Edenberg H.J., Bucholz K., Kramer J., Kuperman S., Bierut L. Genome-wide association study of conduct disorder symptomatology. Mol Psychiatry. 2011;16:800–808. doi: 10.1038/mp.2010.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137.Ochaba J., Monteys A.M., O'Rourke J.G., Reidling J.C., Steffan J.S., Davidson B.L., Thompson L.M. PIAS1 regulates mutant huntingtin accumulation and Huntington's disease-associated phenotypes in vivo. Neuron. 2016;90:507–520. doi: 10.1016/j.neuron.2016.03.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 138.Farrell S.A., Sodhi S., Marshall C.R., Guerin A., Slavotinek A., Paton T., Chong K., Sirkin W.L., Scherer S.W., Bérubé-Simard F.A., Pilon N. HLX is a candidate gene for a pattern of anomalies associated with congenital diaphragmatic hernia, short bowel, and asplenia. Am J Med Genet A. 2017;173:3070–3074. doi: 10.1002/ajmg.a.38354. [DOI] [PubMed] [Google Scholar]
- 139.Rajaraman G., Murthi P., Pathirage N., Brennecke S.P., Kalionis B. Downstream targets of homeobox gene HLX show altered expression in human idiopathic fetal growth restriction. Am J Pathol. 2010;176:278–287. doi: 10.2353/ajpath.2010.090187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140.Suttner K., Ruoss I., Rosenstiel P., Depner M., Pinto L.A., Schedel M., Adamski J., Illig T., Schreiber S., von Mutius E., Kabesch M. HLX1 gene variants influence the development of childhood asthma. J Allergy Clin Immunol. 2009;123:82–88.e6. doi: 10.1016/j.jaci.2008.09.047. [DOI] [PubMed] [Google Scholar]
- 141.Rose J.E., Behm F.M., Drgon T., Johnson C., Uhl G.R. Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. Mol Med. 2010;16:247–253. doi: 10.2119/molmed.2009.00159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.Szafranski P., Gambin T., Dharmadhikari A.V., Akdemir K.C., Jhangiani S.N., Schuette J., Godiwala N., Yatsenko S.A., Sebastian J., Madan-Khetarpal S., Surti U., Abellar R.G., Bateman D.A., Wilson A.L., Markham M.H., Slamon J., Santos-Simarro F., Palomares M., Nevado J., Lapunzina P., Chung B.H., Wong W.L., Chu Y.W., Mok G.T., Kerem E., Reiter J., Ambalavanan N., Anderson S.A., Kelly D.R., Shieh J., Rosenthal T.C., Scheible K., Steiner L., Iqbal M.A., McKinnon M.L., Hamilton S.J., Schlade-Bartusiak K., English D., Hendson G., Roeder E.R., DeNapoli T.S., Littlejohn R.O., Wolff D.J., Wagner C.L., Yeung A., Francis D., Fiorino E.K., Edelman M., Fox J., Hayes D.A., Janssens S., De Baere E., Menten B., Loccufier A., Vanwalleghem L., Moerman P., Sznajer Y., Lay A.S., Kussmann J.L., Chawla J., Payton D.J., Phillips G.E., Brosens E., Tibboel D., de Klein A., Maystadt I., Fisher R., Sebire N., Male A., Chopra M., Pinner J., Malcolm G., Peters G., Arbuckle S., Lees M., Mead Z., Quarrell O., Sayers R., Owens M., Shaw-Smith C., Lioy J., McKay E., de Leeuw N., Feenstra I., Spruijt L., Elmslie F., Thiruchelvam T., Bacino C.A., Langston C., Lupski J.R., Sen P., Popek E., Stankiewicz P. Pathogenetics of alveolar capillary dysplasia with misalignment of pulmonary veins. Hum Genet. 2016;135:569–586. doi: 10.1007/s00439-016-1655-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143.Katoh Y., Katoh M. Hedgehog signaling pathway and gastric cancer. Cancer Biol Ther. 2005;4:1050–1054. doi: 10.4161/cbt.4.10.2184. [DOI] [PubMed] [Google Scholar]
- 144.Soldatov N.M. CACNB2: An emerging pharmacological target for hypertension, heart failure, arrhythmia and mental disorders. Curr Mol Pharmacol. 2015;8:32–42. doi: 10.2174/1874467208666150507093258. [DOI] [PubMed] [Google Scholar]
- 145.Papaioannou A., Higa A., Jégou G., Jouan F., Pineau R., Saas L., Avril T., Pluquet O., Chevet E. Alterations of EDEM1 functions enhance ATF6 pro-survival signaling. FEBS J. 2018;285:4146–4164. doi: 10.1111/febs.14669. [DOI] [PubMed] [Google Scholar]
- 146.Palmieri F. The mitochondrial transporter family SLC25: identification, properties and physiopathology. Mol Aspects Med. 2013;34:465–484. doi: 10.1016/j.mam.2012.05.005. [DOI] [PubMed] [Google Scholar]
- 147.Cordat E., Reithmeier R.A. Structure, function, and trafficking of SLC4 and SLC26 anion transporters. Curr Top Membr. 2014;73:1–67. doi: 10.1016/B978-0-12-800223-0.00001-3. [DOI] [PubMed] [Google Scholar]
- 148.Xu M., Xie Y.A., Abouzeid H., Gordon C.T., Fiorentino A., Sun Z., Lehman A., Osman I.S., Dharmat R., Riveiro-Alvarez R., Bapst-Wicht L., Babino D., Arno G., Busetto V., Zhao L., Li H., Lopez-Martinez M.A., Azevedo L.F., Hubert L., Pontikos N., Eblimit A., Lorda-Sanchez I., Kheir V., Plagnol V., Oufadem M., Soens Z.T., Yang L., Bole-Feysot C., Pfundt R., Allaman-Pillet N., Nitschké P., Cheetham M.E., Lyonnet S., Agrawal S.A., Li H., Pinton G., Michaelides M., Besmond C., Li Y., Yuan Z., von Lintig J., Webster A.R., Le Hir H., Stoilov P., UK Inherited Retinal Dystrophy Consortium. Amiel J., Hardcastle A.J., Ayuso C., Sui R., Chen R., Allikmets R., Schorderet D.F. Mutations in the spliceosome component CWC27 cause retinal degeneration with or without additional developmental anomalies. Am J Hum Genet. 2017;100:592–604. doi: 10.1016/j.ajhg.2017.02.008. [DOI] [PMC free article] [PubMed] [Google Scholar]

